RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Hormone-receptor positive early breast cancer: controversies in the use of adjuvant chemotherapy.
2009-01-01 Montemurro F; Aglietta M.
Imaging as a potential tool for subtyping breast cancer.
2012-01-01 Aglietta M; Montemurro F
Immune checkpoint inhibitors: A new opportunity in the treatment of ovarian cancer?
2016-01-01 Mittica, Gloria; Genta, Sofia; Aglietta, Massimo; Valabrega, Giorgio
Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective.
2014-01-01 Gammaitoni L;Leuci V;Mesiano G;Giraudo L;Todorovic M;Carnevale-Schianca F;Aglietta M;Sangiolo D
International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the fourth symposium on primary systemic therapy in the management of operable breast cancer, cremona, Italy (2010)
2011-01-01 Berruti A; Generali D; Kaufmann M; Puztai L; Curigliano G; Aglietta M; Gianni L; Miller WR; Untch M; Sotiriou C; Daidone M; Conte P; Kennedy D; Damia G; Petronini P; Di Cosimo S; Bruzzi P; Dowsett M; Desmedt C; Mansel RE; Olivetti L; Tondini C; Sapino A; Fenaroli P; Tortora G; Thorne H; Bertolini F; Ferrozzi F; Danova M; Tagliabue E; de Azambuja E; Makris A; Tampellini M; Dontu G; Van't Veer L; Harris AL; Fox SB; Dogliotti L; Bottini A
Is There a Standard Adjuvant Therapy for Resected Pancreatic Cancer?
2019-01-01 Fenocchio, Elisabetta; Filippi, Roberto; Lombardi, Pasquale; Quarà, Virginia; Milanesio, Michela; Aimar, Giacomo; Leone, Francesco; Aglietta, Massimo
Melanoma Brain Metastases in the Era of Target Therapies: An Overview
2020-01-01 Becco, Paolo; Gallo, Susanna; Poletto, Stefano; Frascione, Mirko Pio Manlio; Crotto, Luca; Zaccagna, Alessandro; Paruzzo, Luca; Caravelli, Daniela; Carnevale-Schianca, Fabrizio; Aglietta, Massimo
Next generation immune-checkpoints for cancer therapy
2018-01-01 Donini, Chiara; D'Ambrosio, Lorenzo; Grignani, Giovanni; Aglietta, Massimo; Sangiolo, Dario
NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives
2019-01-01 Lo Nigro, Cristiana; Macagno, Marco; Sangiolo, Dario; Bertolaccini, Luca; Aglietta, Massimo; Merlano, Marco Carlo
Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas
2017-01-01 Vincenzi, Bruno; Badalamenti, Giuseppe; Napolitano, Andrea; Spalato Ceruso, Mariella; Pantano, Francesco; Grignani, Giovanni; Russo, Antonio*; Santini, Daniele; Aglietta, Massimo; Tonini, Giuseppe
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Hormone-receptor positive early breast cancer: controversies in the use of adjuvant chemotherapy. | 2009 | Montemurro F; Aglietta M. | |
| Imaging as a potential tool for subtyping breast cancer. | 2012 | Aglietta M; Montemurro F | |
| Immune checkpoint inhibitors: A new opportunity in the treatment of ovarian cancer? | 2016 | Mittica, Gloria; Genta, Sofia; Aglietta, Massimo; Valabrega, Giorgio | |
| Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective. | 2014 | Gammaitoni L;Leuci V;Mesiano G;Giraudo L;Todorovic M;Carnevale-Schianca F;Aglietta M;Sangiolo D | |
| International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the fourth symposium on primary systemic therapy in the management of operable breast cancer, cremona, Italy (2010) | 2011 | Berruti A; Generali D; Kaufmann M; Puztai L; Curigliano G; Aglietta M; Gianni L; Miller WR; Untch M; Sotiriou C; Daidone M; Conte P; Kennedy D; Damia G; Petronini P; Di Cosimo S; Bruzzi P; Dowsett M; Desmedt C; Mansel RE; Olivetti L; Tondini C; Sapino A; Fenaroli P; Tortora G; Thorne H; Bertolini F; Ferrozzi F; Danova M; Tagliabue E; de Azambuja E; Makris A; Tampellini M; Dontu G; Van't Veer L; Harris AL; Fox SB; Dogliotti L; Bottini A | |
| Is There a Standard Adjuvant Therapy for Resected Pancreatic Cancer? | 2019 | Fenocchio, Elisabetta; Filippi, Roberto; Lombardi, Pasquale; Quarà, Virginia; Milanesio, Michela; Aimar, Giacomo; Leone, Francesco; Aglietta, Massimo | |
| Melanoma Brain Metastases in the Era of Target Therapies: An Overview | 2020 | Becco, Paolo; Gallo, Susanna; Poletto, Stefano; Frascione, Mirko Pio Manlio; Crotto, Luca; Zaccagna, Alessandro; Paruzzo, Luca; Caravelli, Daniela; Carnevale-Schianca, Fabrizio; Aglietta, Massimo | |
| Next generation immune-checkpoints for cancer therapy | 2018 | Donini, Chiara; D'Ambrosio, Lorenzo; Grignani, Giovanni; Aglietta, Massimo; Sangiolo, Dario | |
| NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives | 2019 | Lo Nigro, Cristiana; Macagno, Marco; Sangiolo, Dario; Bertolaccini, Luca; Aglietta, Massimo; Merlano, Marco Carlo | |
| Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas | 2017 | Vincenzi, Bruno; Badalamenti, Giuseppe; Napolitano, Andrea; Spalato Ceruso, Mariella; Pantano, Francesco; Grignani, Giovanni; Russo, Antonio*; Santini, Daniele; Aglietta, Massimo; Tonini, Giuseppe |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 03-CONTRIBUTO IN RIVISTA 50
- 03-CONTRIBUTO IN RIVISTA::03B-Rev... 50
Data di pubblicazione
- 2020 - 2021 4
- 2010 - 2019 41
- 2008 - 2009 5
Rivista
- EXPERT OPINION ON BIOLOGICAL THERAPY 7
- CRITICAL REVIEWS IN ONCOLOGY HEMA... 5
- BREAST CANCER 3
- CANCERS 3
- EXPERT OPINION ON PHARMACOTHERAPY 3
- THE LANCET ONCOLOGY 2
- THE NEW ENGLAND JOURNAL OF MEDICINE 2
- ADVANCES IN THERAPY 1
- ANNALS OF ONCOLOGY 1
- ANNALS OF TRANSLATIONAL MEDICINE 1
Keyword
- breast cancer 7
- immunotherapy 7
- adoptive immunotherapy 5
- HER2 4
- cholangiocarcinoma 3
- CIK 3
- NK 3
- Oncology 3
- sarcomas 3
- solid tumors 3
Lingua
- eng 50
Accesso al fulltext
- reserved 27
- open 15
- partially open 6
- no fulltext 2